In melanoma, IGFBP2 plays additional roles in the activation of the Epidermal Growth Factor Receptor (EGFR)-Signal Transducer adn Activator of Transcripton (STAT3) pathway, activating Programmed Death Ligand 1 (PDL1), and contributing to angiogenesis (24). The gene discussed is EGFR; the disease is melanoma.